Your RPM Tool Is Doing Way More Than You Think

RPM is not a cardiology tool that happens to work in other specialties. It never was. Effective January 1, 2026, CMS finalized CPT code 99445 — the first billable code for monitoring episodes of 2–15 days, a window that fits post-discharge transitions, medication titrations, and seasonal flare monitoring across virtually every chronic condition specialty.

Remote physiologic monitoring is a flexible clinical structure that any practice managing chronic disease patients can deploy for defined, short-duration episodes — and bill for it. According to Nixon Law Group, CPT 99445 reimburses at approximately $47–$52 per 30-day period — the same rate as the legacy 16-day code — despite requiring fewer days of transmitted data.

Medicare RPM claims grew over 3,000% between 2019 and 2023, with more than 13.5 million remote monitoring services delivered, according to a peer-reviewed arXiv analysis. Pulmonology, nephrology, oncology, and endocrinology practices sitting on the sidelines are not being cautious. They are leaving reimbursement — and patient outcomes — on the table.

What the 2-15 Day Monitoring Episode Actually Gives You

CPT 99445, effective January 1, 2026, did something the previous RPM framework never could: it made short-term monitoring financially viable. For the first time, a defined 2–15 day window of remote physiologic data collection is a billable, reimbursable clinical structure — not just a care gap you're filling without compensation.

According to Nixon Law Group (2026), CPT 99445 covers device supply and data transmission for 2–15 days within a 30-day period, reimbursing at approximately the same rate as the legacy 16-day code. As the Nsight Health editorial team put it: "The clinical work was always happening. The reimbursement was not."

What that window actually produces:

• Actionable physiologic data captured during the highest-risk care transitions — post-discharge, medication titration, acute flare-ups
• Documented clinical decision support that justifies interventions and reduces liability exposure
• Reimbursable touchpoints that did not exist under the old 16-day minimum threshold

The episode is condition-agnostic by design. CMS clarified as early as 2020 that RPM codes are not limited to chronic conditions — the 2026 updates simply removed the billing barrier that made deploying them for short windows impractical.

Chronic Conditions Where Short-Duration RPM Makes Clinical Sense

RPM's strongest clinical case isn't cardiology — it's any condition where a short window of objective data changes a clinical decision. Here are four populations where the 2–15 day episode earns its place.

• Hypertension titration: When you adjust a patient's antihypertensive regimen, you're guessing without post-change data. A 2026 JMIR meta-analysis found RPM cohorts achieved systolic blood pressure reductions of 4–9 mmHg — meaningful movement that's invisible if you're waiting 90 days for a follow-up visit.
• COPD exacerbation monitoring: Pulse oximetry via RPM can detect declining oxygen saturation 24–48 hours before symptoms surface, according to HealthArc. For COPD patients post-discharge, that gap is exactly when readmissions happen.
• Diabetes management check-ins: The same JMIR meta-analysis documented A1c reductions of 0.3%–1.22% in RPM cohorts. A 2–15 day window after a medication or lifestyle change gives your care team real glucose trend data, not a single lab snapshot.
• Post-discharge oncology transitions: 50% of oncology readmissions occur within 10 days of discharge, according to JCO Oncology Practice. That's a population where the 2–15 day window isn't just clinically logical — it's the exact intervention window the evidence supports.
• Nephrology / CKD monitoring: More than 1 in 7 American adults have chronic kidney disease, and up to 9 in 10 are unaware of it, per Nsight Health. Continuous blood pressure and weight monitoring during a titration or post-AKI window closes a care gap that quarterly labs simply can't.

These aren't niche edge cases. They're the patients already sitting in your schedule.

How to Identify Strong RPM Candidates in Your Current Patient Panel

Stop searching for the perfect RPM patient. Start looking for the right clinical signals — they're already in your panel.

According to OmniMD, nearly half of all RPM services are delivered by primary care providers, with cardiology, endocrinology, pulmonology, and nephrology close behind. That distribution isn't accidental — it reflects where unstable patients concentrate.

Audit your panel for these high-signal indicators:

• Recent discharge within 30 days — post-acute transitions are CPT 99445's natural home
• Two or more ED visits in the past 12 months — high utilization almost always precedes a preventable readmission
• Active medication titration — hypertension, diabetes, and COPD patients mid-adjustment need data, not just a follow-up call
• Documented non-adherence or missed labs — a care gap is a monitoring opportunity

Diagnosis codes alone will mislead you. A well-controlled diabetic is a lower priority than a newly discharged COPD patient with three prior hospitalizations — regardless of what the EMR flags.

A 2025 peer-reviewed systematic review on PubMed Central confirmed that RPM for oncology patients reduces hospitalizations and ED visits at rates consistent with heart failure and COPD outcomes. The clinical pattern is the same across conditions: instability plus transition equals monitoring opportunity.

Making It Work: Workflow Considerations for Multi-Condition RPM Programs

Expanding RPM across conditions doesn't mean rebuilding your program — it means applying what already works to new patient populations. Mayo Clinic's multisite RPM program spanned 70+ community sites and covered five distinct conditions, from COPD to post-CAR T-cell therapy, using the same core infrastructure. According to JMIR (2023), Haddad et al., 93.58% of patients were satisfied — with no difference in technology ease of use by age group.

The operational lift is in the setup, not the scale. Once staff understand device onboarding, alert thresholds, and documentation workflows for one condition, adapting them for another is incremental — not a rebuild.

Focus your workflow planning on four areas:

• Device logistics: Standardize onboarding checklists per device type, not per condition. A pulse ox workflow for COPD adapts directly to post-discharge oncology monitoring.
• Alert triage: Assign clear ownership. Who reviews flagged readings? Within what timeframe? This breaks down faster than any technology.
• Patient communication: Set transmission expectations at enrollment — not after the first missed reading.
• Documentation: Tie review notes directly to CPT 99445 or 99457/99458 time logs at the point of care, not retrospectively.

The infrastructure you built for your first RPM population is the foundation. Expansion is an adaptation problem, not a construction one.

The 2–15 day monitoring window is not a niche billing workaround. It is a structural tool sitting inside most practices right now, largely unused. According to a peer-reviewed arXiv analysis, 90% of the nation's $4.9 trillion in annual health expenditures goes toward people with chronic and mental health conditions — the exact patients who benefit most from episodic, targeted monitoring.

That is your patient panel. The clinical rationale is already there. The reimbursement structure, with CPT 99445 effective January 1, 2026, is now there too.

Most practices will spend the next 12 months asking whether RPM fits their model. The practices that move now — identifying post-discharge COPD patients, flagging medication titration windows in nephrology, closing the care gap in oncology transitions — will have both the outcomes data and the revenue to show for it.

The 2–15 day episode is not a cardiology tool that other specialties can borrow. It was designed for any condition, any specialty, any patient who needs structured short-term oversight.

The question is no longer whether to expand. It is where to start.

• Talk to a Perfect Rhythm specialist about expanding RPM strategically across your patient population.
• Download our RPM candidate checklist to identify eligible patients in your current panel.
• Schedule a workflow assessment to see where episodic monitoring fits your clinical model — without rebuilding from scratch.

Frequently Asked Questions

What is the 2–15 day RPM monitoring episode used for?

The 2–15 day monitoring episode, now billable under CPT 99445 effective January 1, 2026, is designed for short-term remote physiologic monitoring outside the traditional 16-day minimum. It is particularly suited for post-discharge transitions, medication titration windows, and episodic condition flare-ups across specialties including pulmonology, nephrology, oncology, and endocrinology.

Is RPM reimbursable for conditions beyond heart failure?

Yes. According to HealthSnap's RPM billing overview, CMS clarified as early as 2020 that RPM codes are not limited to chronic or cardiac conditions. The 2026 updates explicitly support episodic and acute use, making RPM reimbursable across a wide range of diagnoses when documentation requirements are met.

How do practices identify which patients qualify for episodic RPM?

Strong candidates include patients who are post-discharge within 30 days, undergoing medication adjustments, or showing high utilization signals such as frequent ED visits or prior readmissions. Clinical indicators matter more than diagnosis codes — focus on patients where real-time data would change a clinical decision within a defined window.

Does expanding RPM across specialties require new infrastructure?

Not necessarily. Practices already running RPM programs can adapt existing device inventory, alert workflows, and staff touchpoints to serve additional condition populations. The operational lift comes from workflow design, not hardware — and AI-integrated platforms are increasingly handling triage and alert prioritization to manage data volume at scale.

What happened with UnitedHealthcare's attempt to restrict RPM coverage?

UnitedHealthcare proposed limiting RPM coverage to only two conditions — chronic heart failure and hypertensive disorders of pregnancy — but the policy was indefinitely delayed as of May 2026 following significant industry pushback, according to Prevounce. Medicare continues to support broad RPM use across conditions, reinforcing the strategic value of Medicare-anchored program design.